首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
【24h】

Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.

机译:保留乳房手术和全乳放疗后,淋巴结阴性的t1至t2乳腺癌患者的局部和区域复发风险较高。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate locoregional recurrence according to nodal status in women with T1 to T2 breast cancer and zero to three positive nodes (0-3N+) treated with breast-conserving surgery (BCS). METHODS AND MATERIALS: The study subjects comprised 5,688 women referred to the British Columbia Cancer Agency between 1989 and 1999 with pT1 to T2, 0-3N+, M0 breast cancer, who underwent breast-conserving surgery with clear margins and radiotherapy (RT) of the whole breast. The 10-year Kaplan-Meier local, regional, and locoregional recurrence (LR, RR, and LRR, respectively) were compared between the N0 (n = 4,433) and 1-3N+ (n = 1,255) cohorts. The LRR was also examined in patients with one to three positive nodes (1-3N+) treated with and without nodal RT. Multivariate analysis was performed using Cox regression modeling. RESULTS: Median follow-up was 8.6 years. Systemic therapy was used in 97% of 1-3N+ and 41% of N0 patients. Nodal RT was used in 35% of 1-3N+ patients. The 10-year recurrence rates in N0 and 1-3N+ cohorts were as follows: LR 5.1% vs. 5.8% (p = 0.04); RR 2.3% vs. 6.1% (p < 0.001), and LRR 6.7% vs. 10.1% (p < 0.001). Among 817 1-3N+ patients treated without nodal RT, 10-year LRR were 13.8% with age <50 years, 20.3% with Grade III, and 23.4% with estrogen receptor (ER)-negative disease. On multivariate analysis, 1-3N+ status was associated with significantly higher LRR (hazard ratio [HR], 1.85; 95% confidence interval, 1.34-2.55, p < 0.001), whereas nodal RT significantly reduced LRR (HR, 0.59; 95% confidence interval, 0.38-0.92, p = 0.02). CONCLUSION: Patients with 1-3N+ and young age, Grade III, or ER-negative disease have high LRR risks approximating 15% to 20% despite BCS, whole-breast RT and systemic therapy. These patients may benefit with more comprehensive RT volume encompassing the regional nodes.
机译:目的:根据乳腺癌保乳手术(BCS)治疗的T1至T2乳腺癌和零至三个阳性淋巴结(0-3N +)的妇女,根据淋巴结状态评估局部复发。方法和材料:研究对象包括5688名在1989年至1999年之间转诊至不列颠哥伦比亚癌症机构的女性,其中pT1至T2、0-3N +,M0乳腺癌,她们接受了保乳术,有明显的切缘和放射疗法(RT)。整个乳房。比较了N0(n = 4,433)和1-3N +(n = 1,255)队列的10年Kaplan-Meier局部,区域和局部复发率(分别为LR,RR和LRR)。还对接受或不接受淋巴结放疗的一到三个阳性淋巴结(1-3N +)患者进行了LRR检查。使用Cox回归模型进行多变量分析。结果:中位随访时间为8.6年。 97%的1-3N +患者和41%的N0患者使用了全身疗法。 Nodal RT用于1-3N +患者中的35%。 N0和1-3N +人群的10年复发率如下:LR 5.1%vs. 5.8%(p = 0.04); RR分别为2.3%和6.1%(p <0.001)和LRR 6.7%和10.1%(p <0.001)。在817例1-3N +无结节放疗的患者中,年龄<50岁的10年LRR为13.8%,III级为20.3%,雌激素受体(ER)阴性为23.4%。在多变量分析中,1-3N +状态与LRR显着升高相关(危险比[HR],1.85; 95%置信区间,1.34-2.55,p <0.001),而节点RT显着降低LRR(HR,0.59; 95%置信区间0.38-0.92,p = 0.02)。结论:尽管有BCS,全乳放疗和全身治疗,但1-3N +和年轻,III级或ER阴性的患者具有较高的LRR风险,约15%至20%。这些患者可能受益于涵盖区域性淋巴结的更全面的RT量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号